Clinical trial Recruiting at 1 site Observational

Mapping how the human retinal and visual brain tissues develop

Official title: Mapping of the Developmental Atlas of the Visual System and Research on Embryonic Neurogenesis Phenomena

Run by Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07688538 · Data updated 2026-11-12

This study tests how retinal nerve cells and related brain regions grow and connect in human embryos, using donated embryonic tissues from terminated pregnancies.

Quick facts

Study typeObservational
SexAll
Enrollment200 (estimated)
SponsorZhongshan Ophthalmic Center, Sun Yat-sen University
Academic / other
Locations1 site (Guangzhou, Guangdong)
StatusRecruiting
StartedJanuary 16, 2026
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedJuly 7, 2026
Trial IDNCT07688538 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are embryos with documented developmental abnormalities and intact ocular and brain tissues suitable for multi-omics and functional experiments, as well as embryos without defects confirmed by prenatal assessments.

Probably not a fit

Tissues from embryos with severe damage or contamination or whose donors withdraw consent may not yield benefit to future patients.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Researchers will collect eye and brain tissues from embryos with and without developmental abnormalities and apply single-cell sequencing, multi-omics analyses, and functional measurements to map gene activity, growth pathways, and neural connections. They will use Patch-seq, high-density microelectrode arrays, and two-photon calcium imaging to examine electrical activity, cell shape, synaptic connections, and signal coding in retina and visual cortex. The goal is to create a developmental atlas of the visual system and related cognitive regions to understand how early neurogenesis shapes later function. All samples are obtained with informed consent and appropriate ethical oversight. The study is observational and focuses on tissue collection and advanced sequencing analysis rather than interventional procedures.

Why it matters

Potential benefit: The research could provide a detailed map of early visual system development that may inform understanding of retinal and brain developmental anomalies.

How similar studies have gone: Prior work in developmental neuroscience has advanced multi-omics and electrophysiological mapping, but this exact combination in human embryonic visual system development is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Abnormal group: Embryos with clinically confirmed embryonic developmental abnormalities requiring medical termination of pregnancy; intact retinal, visual and cognitive brain tissues available for snATAC-seq, scRNA-seq, electrophysiology, proteomics and RNAscope detection.

Normal group: Embryos confirmed free of any ocular and central nervous developmental defects by prenatal examination and anatomical observation; intact embryonic ocular and brain tissues meeting all experimental detection standards.

All sample donors have signed written informed consent authorizing the use of residual embryonic tissues for scientific research, with no monetary compensation involved.

Exclusion Criteria:

* Embryonic ocular or brain tissues with severe necrosis, structural damage or microbial contamination that cannot support multi-omics and functional experiments.

Donors who withdraw or refuse the consent for tissue research use. Samples with irregular collection, transportation or cryopreservation procedures resulting in tissue degradation and failure to meet experimental requirements.

Where it's running

  • Zhongshan Ophthalmic Center, Sun Yat-sen University
    Guangzhou, Guangdong, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.